HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the efficacy of RF microneedling and oral isotretinoin in comparison with oral isotretionoin alone in the treatment of acne vulgaris.

AbstractIntroduction:
Acne vulgaris is one of the most common skin illnesses in teenagers, affecting 80% of people aged 11-30 years. Scars on the face are caused by high inflammation, severe acne, physical manipulation of the skin, and delayed treatment.
Aim:
To compare the effectiveness and safety of an automated RF micro needling device and oral isotretinoin with oral isotretinon alone alone for treating active acne.
Material and methods:
A cross-sectional study of 40 moderate acne sufferers. Twenty patients with active acne were treated with an automated RF microneedling device and isotretinoin 0.5-1 mg/kg. Group B included 20 people with active acne, who were given a single dose of 0.5-1 mg/kg isotretinoin.
Results:
In this cross-sectional research, 40 acne vulgaris patients were divided into 2 groups: group A: 23.8 ±3.2 years old, 58.95 ±5.5 kg, 13 females, and 7 males. There were 15 females and 5 males in group B: 24.4 ±3.7 years old and weighing 56.4 ±8.46 kg. After 12 weeks, group A shows better global acne assessment scale (GAAS) outcomes than group B than group B. After 6 months, group A showed better results than group B. The GAAS meaning global acne assessment scale did not change after 4-8 weeks of treatment. There was no age or weight difference.
Conclusions:
Acne vulgaris may be treated with fractional RF microneedling. Active acne treatment with RF microneedling is safe and effective, has a quicker response, causes less scarring, and reduces recurrence.
AuthorsIntisar Ahmed Hasan, Zahraa Najah Mahdi, Rana Khalid Obeed
JournalPostepy dermatologii i alergologii (Postepy Dermatol Alergol) Vol. 40 Issue 1 Pg. 111-114 (Feb 2023) ISSN: 1642-395X [Print] Poland
PMID36909913 (Publication Type: Journal Article)
CopyrightCopyright: © 2023 Termedia Sp. z o. o.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: